PreciControl HBsAg II - Hepatitis B virus surface antigen IVD, control

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Roche Diagnostics Australia Pty Limited

Classe:

Class 4

Prodotto da:

Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany

Area terapeutica:

42000 - Hepatitis B virus surface antigen IVD, control

Indicazioni terapeutiche:

A ready to use control serum based on human serum both in the negative and positive concentration range. For quality control of the Elecsys HBsAg II and Elecsys HBsAg II Auto Confirm immunoassays on the Elecsys and cobas e immunoassay analysers.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2013-09-13